As shown in Fig. 3a, b, and c, deletion of Trim6 in combination with anti-PD-L1 treatment increased the proportions of CD8+ and CD8+ GZMB+ T cells but not those of CD4+ T cells in MTC tumors. The gene discussed is CD4; the disease is medullary thyroid gland carcinoma.